CSNK1A1 and adenocarcinoma: This would suggest a further single sporadic mutation, for example in Csnk1a1, could drive rapid progression to adenocarcinoma and metastasis in the KPN model, possibly by generating an inflammatory TME (Pribluda et al., 2013).